Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Semaglutide and Long-Term Weight Loss One landmark trial, the STEP (Semaglutide Treatment Effect in People with Obesity) program, has yielded promising results
Both classes reduce hunger, so combined use can drive caloric intake very low
Some VivioMD marketing pages use guarantee-oriented language - one states the company is confident enough in its program to "guarantee you'll lose weight or your money back." The current, publicly posted Refund Policy - last updated June 15, 2026, and reconfirmed live for this article - states something different and more specific: "There is no guarantee of results or effectiveness of any treatment or care plan provided to you as part of your participation or use of the Subscription Services." An earlier, separate 2026 review of the brand described a specific refund structure tied to losing 10% of body weight over 24 consecutive weeks
Semaglutide GLP-1 is part of a class of drugs known as glucagon-like-peptide 1 receptor antagonists, or simply GLP-1 receptor antagonists
Originally developed to treat type 2 diabetes, semaglutide and other similar GLP-1 medications have found demand in the market as weight loss medications when used together with diet and exercise to help individuals with at least one weight-related medical condition
US$ 23.96
US$ 25.77
US$ 27.24
.webp?width=900&height=1201&name=Semaglutide%20Image%202_900x1200%20(without%20phone).webp)